Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma von Lin, Chi, Verma, Vivek, Ly, Quan P., Lazenby, Audrey, Sasson, Aaron, Schwarz, James K., Meza, Jane L., Are, Chandrakanth, Li, Sicong, Wang, Shuo, Hahn, Stephen M., Grem, Jean L.

Volltext

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003 von Dudek, Arkadiusz Z, Liu, Li C, Gupta, Shilpa, Logan, Theodore F, Singer, Eric A, Joshi, Monika, Zakharia, Yousef N, Lang, Joshua M, Schwarz, James K, Al-Janadi, Anas, Alva, Ajjai S

Volltext

Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck von Tang, Patricia A., Siu, Lillian L., Chen, Eric X., Hotte, Sebastien J., Chia, Stephen, Schwarz, James K., Pond, Gregory R., Johnson, Caitlin, Colevas, A. Dimitrios, Synold, Timothy W., Vasist, Lakshmi S., Winquist, Eric

Volltext

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint von Basch, Ethan M., Scholz, Mark, de Bono, Johann S., Vogelzang, Nicholas, de Souza, Paul, Marx, Gavin, Vaishampayan, Ulka, George, Saby, Schwarz, James K., Antonarakis, Emmanuel S., O'Sullivan, Joseph M., Kalebasty, Arash Rezazadeh, Chi, Kim N., Dreicer, Robert, Hutson, Thomas E., Dueck, Amylou C., Bennett, Antonia V., Dayan, Erica, Mangeshkar, Milan, Holland, Jaymes, Weitzman, Aaron L., Scher, Howard I.

Volltext

A phase 1 clinical trial of sequential pralatrexate followed by a 48‐hour infusion of 5‐fluorouracil given every other week in adult patients with solid tumors von Grem, Jean L., Kos, Mary E., Evande, Ruby E., Meza, Jane L., Schwarz, James K.

Volltext

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients with Advanced Solid Tumors von FAKIH, Marwan G, CREAVEN, Patrick J, ZAMBONI, William C, RAMNATH, Nithya, TRUMP, Donald, JAVLE, Milind, STRYCHOR, Sandra, REPINSKI, Trisha V. W, ZAMBONI, Beth A, SCHWARZ, James K, FRENCH, Renee A

Volltext

Expression of transcription factor E2F1 induces quiescent cells to enter S phase von Johnson, David G, Schwarz, James K, Cress, W. Douglas, Nevins, Joseph R

Volltext

Retinoblastoma Gene Product as a Downstream Target for a Ceramide-Dependent Pathway of Growth Arrest von Dbaibo, Ghassan S., Pushkareva, Marina Y., Jayadev, Supriya, Schwarz, James K., Horowitz, Jonathan M., Obeid, Lina M., Hannun, Yusuf A.

Volltext

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival... von Petrylak, Daniel P, de Wit, Ronald, Chi, Kim N, Drakaki, Alexandra, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Hussain, Syed A, Fléchon, Aude, van der Heijden, Michiel S, Matsubara, Nobuaki, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Percent, Ivor J, Lee, Jae-Lyun, Laestadius, Fredrik, Peer, Avivit, Garcia del Muro, Xavier, Cicin, Irfan, Vaishampayan, Ulka, Aragon-Ching, Jeanny B, Hamid, Oday, Wijayawardana, Sameera, Russo, Francesca, Zimmermann, Annamaria H, Bell-McGuinn, Katherine M, Wong, Suet-Lai Shirley, Tan, Thean Hsiang, Hovey, Elizabeth Jane, Clay, Timothy Dudley, Wan Ng, Siobhan Su, Rutten, Annemie, Dumez, Herlinde, Ferrario, Cristiano, Sengeloev, Lisa, Jensen, Niels Viggo, Thibault, Constance, Laguerre, Brigitte, Joly, Florence, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Stöckle, Michael, Grimm, Marc-Oliver, Schultze-Seemann, Wolfgang, Kalofonos, Haralambos, Mavroudis, Dimitrios, Karavasilis, Vasilis, Révész, Janos, Leibowitz-Amit, Raya, Kejzman, Daniel, Sarid, David, Massari, Francesco, Osawa, Takahiro, Miyajima, Naoto, Shinohara, Nobuo, Fukuta, Fumimasa, Ohyama, Chikara, Obara, Wataru, Yamashita, Shinichi, Tomita, Yoshihiko, Kawai, Koji, Oyama, Masafumi, Yonese, Junji, Uemura, Motohide, Tsunemori, Hiroyuki, Yokomizo, Akira, Nagamori, Satoshi, Lee, Hyo Jin, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Lee, Yun-Gyoo, Vazquez Cortés, Leticia, Lorena Urzua Flores, Claudia, Blaisse, Reinoud J.B., Aarts, Maureen J.B., Schenker, Michael, Herzal, Alina Amalia, Udrea, Anghel Adrian, Karlov, Petr, Fomkin, Roman, Grande, Enrique, Lin, Chia-Chi, Yeh, Su-Peng, Erman, Mustafa, Urun, Yuksel, Golovko, Yuriy, Sinielnikov, Ivan, Crabb, Simon J., Syndikus, Isabel, Sundar, Santhanam, Pan, Chong Xian, Schwarz, James K., Acs, Peter Istvan, Hainsworth, John D., Lawler, William Eyre

Volltext

Expression of the E2F1 Transcription Factor Overcomes Type β Transforming Growth Factor-Mediated Growth Suppression von Schwarz, James K., Bassing, Craig H., Kovesdi, Imre, Datto, Michael B., Blazing, Michael, George, Samuel, Wang, Xiao-Fan, Nevis, Joseph R.

Volltext

Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study von Ramnath, Nithya, Yu, Jihnhee, Khushalani, Nikhil I, Gottlieb, Ronald H, Schwarz, James K, Iyer, Renuka V, Rustum, Youcef M, Creaven, Patrick J

Volltext

A phase II study of neodjuvant chemoimmunotherapy followed by stereotactic radiotherapy/nelfinavir in patients with locally advanced CA125 expressing pancreatic adenocarcinoma von Lin, Chi, Ly, Quan P., Berim, Lyudmyla Derby, Schwarz, James K., Madiyalakan, Madi, Nicodemus, Christopher F., Hollingsworth, Michael A., Meza, Jane L, Are, Chandrakanth, Padussis, James, Grem, Jean L.

Volltext

Phase ib and phase II studies of pembrolizumab (P) with bevacizumab (B) for the treatment of metastatic renal cell carcinoma (RCC): BTCRC-GU14-003 von Dudek, Arkadiusz Z., Liu, Li C, Alva, Ajjai Shivaram, Stein, Mark, Gupta, Shilpa, Albany, Costantine, Joshi, Monika, Zakharia, Yousef, Lang, Joshua Michael, Schwarz, James K., Al-Janadi, Anas

Volltext

Pleural mesothelioma with cutaneous extension to chest wall scars von Shieh, Sherry, Grassi, Marcelle, Schwarz, James K., Cheney, Richard T.

Volltext

A phase I study of ADH-1 with cisplatin (Cisp) and gemcitabine (Gem) in patients (Pts) with unresectable or metastatic pancreatic and biliary tract cancers von Berim, Lyudmyla Derby, Kos, Beth M, Evande, Ruby, Meza, Jane L, Shostrom, Valerie, Schwarz, James K., Grem, Jean L.

Volltext

PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors von Vaena, Daniel A., Chaves, Jorge, Vogelzang, Nicholas J., Matrana, Marc Ryan, Gabayan, A. Eli, Riese, Matthew John, Cho, Daniel C., Tagliaferri, Mary Ann, Zalevsky, Jonathan, Xie, Sunny, Hoch, Ute, RIZWAN, AHSAN NAQI, Aung, Sandra, Imperiale, Michael, Schwarz, James K.

Volltext

Phase I trial of metronomic cyclophosphamide (CTX) and lenalidomide (LEN) in patients with castration-resistant prostate cancer (CRPC) von Wang, Jue, McGuire, Timothy R., Schwarz, James K., Meza, Jane L, E Talmadge, James E

Volltext

Survival outcome of a phase I trial: Hypofractionated stereotactic body radiation therapy concurrent with nelfinavir following gemcitabine and 5FU in patients with locally advanced... von Lin, Chi, Sasson, Aaron R., Ly, Quan P., Schwarz, James K., Are, Chandrakanth, Kos, Beth M, Lazenby, Audrey J, Ketcham, Marsha A, Sehi, Eugene D, Grem, Jean L.

Volltext

Final analysis of COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to severe... von Basch, Ethan M., Scholz, Mark C., De Bono, Johann Sebastian, Vogelzang, Nicholas J., De Souza, Paul L., Marx, Gavin M., Vaishampayan, Ulka N., George, Saby, Schwarz, James K., Antonarakis, Emmanuel S., O'Sullivan, Joe M., Rezazadeh Kalebasty, Arash, Chi, Kim N., Dreicer, Robert, Hutson, Thomas E., Mangeshkar, Milan, Holland, Jaymes S., Weitzman, Aaron, Scher, Howard I.

Volltext

E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis von Kowalik, T F, DeGregori, J, Schwarz, J K, Nevins, J R

Volltext